ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TKNO vs ACHV // EV/EBITDA & P/E VALUATION

Alpha Teknova Inc. (NASDAQ) VS. Achieve Life Sciences Inc. (NASDAQ) • 15-METRIC TALLY: TKNO 4 — ACHV 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TKNO VS. ACHV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TKNO ACHV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 33.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -21.30% -35.00% +13.70 TKNO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -1.96% -6.69% +4.73 TKNO /fcf-yield <GO>
Operating Margin -41.90% — — TIE /operating-margins <GO>
Net Profit Margin -42.60% — — TIE /net-margins <GO>
Revenue Growth (YoY) 7.40% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.93 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 TKNO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.1 46.4 +1.69 TKNO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $499.2M $739.9M -$240.7M ACHV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TKNO REV ACHV REV TKNO GROSS % ACHV GROSS % TKNO FCF ACHV FCF
FY 2025 $40.5M $0 33.2% — -$9.8M -$49.5M
FY 2024 $37.7M $0 19.2% — -$13.5M -$29.8M
FY 2023 $36.7M $0 — — -$18.8M -$24.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TKNO // BETA —
ACHV // BETA —